Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L G Durrant

Showing results (61-70 of 86) with videos related to

Pageof 9
Sort By:
Cancer Research|July 1, 1986
Association of antigen expression and DNA ploidy in human colorectal tumorsL G Durrant, R A Robins, N C Armitage, et al.
Clinical Immunology (Orlando, Fla.)|May 30, 2008
T-cell responses in osteosarcoma patients vaccinated with an anti-idiotypic antibody, 105AD7, mimicking CD55G J Ullenhag, I Spendlove, N F S Watson, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1991
Reactivity of an anti-(human gastric carcinoma) monoclonal antibody with core-related peptides of gastrointestinal mucinM R Price, M Sekowski, G Y Yang, et al.
British Journal of Cancer|March 15, 2012
The chemokine, CXCL12, is an independent predictor of poor survival in ovarian cancerA Popple, L G Durrant, I Spendlove, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1989
Abrogation of antibody responses in rats to murine monoclonal antibody 791T/36 by treatment with daunomycin-cis-aconityl-791T/36 conjugatesL G Durrant, R A Robins, R A Marksman, et al.
Cancer Research|October 1, 1991
Antitumor immune response and interleukin 2 production induced in colorectal cancer patients by immunization with human monoclonal anti-idiotypic antibodyR A Robins, G W Denton, J D Hardcastle, et al.
International Journal of Cancer|April 1, 1994
Clinical outcome of colorectal cancer patients treated with human monoclonal anti-idiotypic antibodyG W Denton, L G Durrant, J D Hardcastle, et al.
British Journal of Cancer|December 1, 1989
Enhanced recognition of human colorectal tumour cells using combinations of monoclonal antibodiesL G Durrant, R A Robins, K C Ballantyne, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2000
A neoadjuvant clinical trial in colorectal cancer patients of the human anti-idiotypic antibody 105AD7, which mimics CD55L G Durrant, C Maxwell-Armstrong, D Buckley, et al.
Cancer Research|September 15, 1994
Enhanced cell-mediated tumor killing in patients immunized with human monoclonal antiidiotypic antibody 105AD7L G Durrant, T J Buckley, G W Denton, et al.
Pageof 9

Showing results (61-70 of 86) with videos related to

Sort By:
Pageof 9
Cancer Research|July 1, 1986
Association of antigen expression and DNA ploidy in human colorectal tumorsL G Durrant, R A Robins, N C Armitage, et al.
Clinical Immunology (Orlando, Fla.)|May 30, 2008
T-cell responses in osteosarcoma patients vaccinated with an anti-idiotypic antibody, 105AD7, mimicking CD55G J Ullenhag, I Spendlove, N F S Watson, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1991
Reactivity of an anti-(human gastric carcinoma) monoclonal antibody with core-related peptides of gastrointestinal mucinM R Price, M Sekowski, G Y Yang, et al.
British Journal of Cancer|March 15, 2012
The chemokine, CXCL12, is an independent predictor of poor survival in ovarian cancerA Popple, L G Durrant, I Spendlove, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1989
Abrogation of antibody responses in rats to murine monoclonal antibody 791T/36 by treatment with daunomycin-cis-aconityl-791T/36 conjugatesL G Durrant, R A Robins, R A Marksman, et al.
Cancer Research|October 1, 1991
Antitumor immune response and interleukin 2 production induced in colorectal cancer patients by immunization with human monoclonal anti-idiotypic antibodyR A Robins, G W Denton, J D Hardcastle, et al.
International Journal of Cancer|April 1, 1994
Clinical outcome of colorectal cancer patients treated with human monoclonal anti-idiotypic antibodyG W Denton, L G Durrant, J D Hardcastle, et al.
British Journal of Cancer|December 1, 1989
Enhanced recognition of human colorectal tumour cells using combinations of monoclonal antibodiesL G Durrant, R A Robins, K C Ballantyne, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2000
A neoadjuvant clinical trial in colorectal cancer patients of the human anti-idiotypic antibody 105AD7, which mimics CD55L G Durrant, C Maxwell-Armstrong, D Buckley, et al.
Cancer Research|September 15, 1994
Enhanced cell-mediated tumor killing in patients immunized with human monoclonal antiidiotypic antibody 105AD7L G Durrant, T J Buckley, G W Denton, et al.
Pageof 9